Amendments from Version 1
Amendments from Version 1
In response to the reviewers' comments, we revised our paper and the major changes are listed below. Overall, we further emphasized the limitations of this study in the Discussion section, to help other researchers who want to characterize C. elegans arrd genes to ensure they interpret our results with caution. 1. We changed the title to objectively reflect our results 2. We discussed the RNAi efficiency issues, which are the biggest pitfall of our research. In addition, we addressed possible off-target effects of arrd RNAi in the Methods section 3. We described the reason why we did not test the remaining 5 arrd genes and discussed their potential importance in lifespan regulation in the Methods and Discussion sections 4. We mentioned the phenotype conferred by arrd RNAi that we observed during our lifespan screen 5. We have added a new Supplementary Table S1 (Possible RNAi target prediction), and the previous Supplementary  Table S1 is now designated as Supplementary Table S2 (Lifespan data of Caenorhabditis elegans α-arrestin RNAi clones)
See referee reports

REVISED
Introduction
α-arrestins are a family of proteins that contain arrestin domains whose sequences and structures have similarities with those of classical visual and β-arrestins 1-3 . α-arrestins are considered as ancestral forms of arrestins because their orthologs exist in fungi, including yeast, which do not have visual or β-arrestins 1, 4 . Several mammalian α-arrestins modulate metabolism and receptor desensitization 5, 6 , but much remains to be elucidated concerning the functions of α-arrestins in many organisms. The human genome encodes 6 α-arrestins and 4 visual or β-arrestins. Interestingly, the simple roundworm Caenorhabditis elegans genome contains 29 α-arrestin and 1 β-arrestin genes 1, 7 . Therefore, the C. elegans system provides opportunities for the genetic analysis of α-arrestins in various aspects of physiology both individually and combinatorially. However, information regarding the functions of C. elegans α-arrestins is limited 8, 9 . C. elegans is an excellent genetic model organism that has been exploited for studying conserved biological processes, including apoptosis, behavior, development and aging. In particular, its short lifespan in combination with genetic amenability has made C. elegans one of the most popular models for research on aging and longevity 10, 11 . Many factors, including components in insulin/ insulin-like growth factor 1 (IGF-1) signaling (IIS), have been identified as lifespan and aging regulators in C. elegans [11] [12] [13] . For example, genetic inhibition of IIS components, such as DAF-2/insulin/IGF-1 receptor, robustly extends lifespan and delays physiological aging through up-regulating transcription factors, including DAF-16/FOXO [11] [12] [13] . Importantly, the roles of these aging-regulatory factors in C. elegans have been shown to be conserved in other species, including Drosophila and mammals 12, 13 . One of the powerful ways to identify novel factors that influence aging is by employing genetic screens, such as an RNA interference (RNAi) screen. We previously identified several genetic factors, including RNA helicases, that modulate longevity in C. elegans, through targeted or genome-wide RNAi screens [14] [15] [16] [17] . Because of its robust longevity phenotype that confers sensitivity to changes in lifespan, daf-2/insulin/IGF-1 receptor mutants serve as an excellent platform for the identification of novel lifespan-regulating factors 17, 18 .
In this study, we aimed to determine whether any α-arrestins played a role in the lifespan regulation of wild-type or daf-2 mutants. We performed a lifespan assay-based RNAi screen targeting 24 out of 29 C. elegans α-arrestins. We found that knocking down each of the α-arrestins had small or no effects on the lifespan of wild-type and daf-2 mutants. Thus, C. elegans α-arrestins may play minor or modulatory roles in lifespan regulation. Based on our results, it will be important to test the roles of α-arrestins in combinatorial manners and/or by using strong loss-of-function mutations in future research.
Methods
Caenorhabditis elegans strains
All strains were maintained as previously described
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. The following strains were used in this study: N2 wild-type, CF1041 daf-2(e1370) III outcrossed six times to N2.
Phylogenetic analysis
The protein sequences of 27 α-arrestins, except arrd (arrestin domain protein)-20 and arrd-21, were obtained from Wormbase (www.wormbase.org, version WS259). The protein sequences of arrd-20 and arrd-21 were obtained from Ensembl (http://www.ensembl.org, release 89). The phylogenetic tree of 29 α-arrestins in C. elegans was generated using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) 20 and re-visualized using the Dendroscope 3 (version 3.5.9) 21 . For the α-arrestins that have multiple isoforms, isoform a was used for the analysis.
RNAi clones
Twenty one RNAi clones that target C. elegans α-arrestin genes were used from two commercial C. elegans RNAi feeding libraries. Specifically, RNAi clones targeting arrd -2, arrd-6, arrd-7, arrd-8, arrd-9, arrd-10, arrd-13, arrd-16, arrd-18, arrd-23, arrd-24, arrd-25, arrd-28 and ttm-2 (toxin-regulated targets of MAPK 2) were obtained from Ahringer laboratory library (Geneservice Ltd., Cambridge, UK), while those against arrd -1, arrd-3, arrd-4, arrd-5, arrd-14, arrd-15 and arrd-19 were from Vidal laboratory library (Source BioScience, Nottingham, UK). Three RNAi clones targeting arrd-11, arrd-17, and arrd-26 were generated by molecular cloning using infusion recombinase (EZ-Fusion TM Cloning Kit, Enzynomics, Daejeon, South Korea). The N2 genomic DNA was obtained through the lysis of worms using proteinase K (Invitrogen, Carlsbad, CA, USA) and N2 complementary DNA was obtained from RNA extraction using RNAiso Plus (Takara, Shiga, Japan) followed by reverse transcription using ImProm-II reverse transcriptase (Promega, Madison, WI, USA, USA). The infusion reaction between PCR products and pL4440 plasmids (Fire lab C. elegans vector kit, 1999) digested with HindIII (New England Biolabs, Ipswich, MA, USA) and Acc65I (New England Biolabs) was followed by transformation of in-house competent E. coli HT115 cells and by selection of positive clones on ampicillin (USB, Santa Clara, CA, USA)-containing LB plates. Primers (CosmoGenetech, Seoul, South Korea) that were used to amplify coding regions of arrd-11 from N2 genomic DNA, and those of arrd-17 and arrd-26 from N2 complementary DNA are as follows: forward primer 5'-GAATTCGATATCAAGCTC-CCTCGTGCAAATTAGGAAA-3' and reverse primer 5'-CTATAG-GGCGAATTGGGGTTCCTCCCACTCCATACA-3' for arrd-11; forward primer 5'-GAATTCGATATCAAGCTATGGTGCAGTTA-GATCGTTTTG-3' and reverse primer 5'-CTATAGGGCGAATT-GGTTAATCGGTATAAAATGG-3' for arrd-17; forward primer 5'-GAATTCGATATCAAGCTATGAAGGTCGATTACTTCG-3' and reverse primer 5'-CTATAGGGCGAATTGGCTACTTCTCG-GAGCCATTTG-3' for arrd-26. The sequences of all these 24 α-arrestin RNAi clones were confirmed using DNA sequencing (Solgent, Daejeon, South Korea) before lifespan assays. RNAi clones for arrd-12, arrd-22, and arrd-27 were not generated because of unknown technical problems and were not included in the lifespan screen. arrd-20 and arrd-21 are predicted to be pseudogenes (Wormbase, version WS259) and were excluded from our screen. All RNAi clones used in our screen were examined for their potential off-target effects by using Clone Mapper (http://bioinformatics.lif.univ-mrs.fr/RNAiMap) 22 , and no significant off-target was predicted except arrd-19 RNAi, which may additionally target a predicted pseudogene arrd-21, (Table S1 ). Experimental validation by qRT-PCR will be necessary to completely exclude the possible off-target effects caused by RNAi clones. Table S2 for statistical analysis.
RNAi screen using lifespan assay The RNAi screen employing lifespan assay was performed as previously described 17 . Briefly, E. coli HT115 bacteria that expressed specific double-stranded RNAs (dsRNAs) were cultured overnight at 37°C in LB media containing 50 μg/ml ampicillin (USB). The cultured bacteria were seeded onto nematode growth media plates containing 50 μg/ml ampicillin and incubated overnight at 37°C. The seeded bacteria were treated with 1 mM isopropyl β-D-1-thiogalactopyranoside (Gold Biotechnology, St. Louis, MO, USA) and incubated at room temperature for approximately 24 h to induce dsRNAs. Age-synchronized wild-type N2 and daf-2(e1370) mutant animals were grown on RNAi plates from embryo to L4 stage at 20°C. Worms were then transferred onto RNAi plates containing 5 μM 5-fluoro-2'deoxyuridine (FUdR; Sigma, St. Louis, MO, USA), which prevents eggs from hatching, at young (day 1) adult stage, and transferred again to new FUdR-containing RNAi plates after 1 or 2 days. Eggs laid by ttm-2 RNAi-treated worms hatched more frequently than control eggs on FUdR-containing plates in two independent lifespan experiments. All lifespan assays were performed at 20°C as duplicates by two independent researchers. The survival of worms was determined by gently touching worms with a platinum wire. Worms that did not respond were counted as dead worms and removed from the plates. Worms that crawled off the plates, burrowed into the agar media, or displayed internal hatching or vulval rupture were censored, but included in the statistical analysis. Lifespan data from two independent lifespan experiments within the experimental sets were pooled and used for statistical analysis (see Dataset 1-Dataset 3). OASIS 2 (Online Application for Survival Analysis 2; https://sbi.postech.ac.kr/oasis2) 23 was used for the statistical analysis of lifespan results. P values were calculated using long-rank (Mantel-Cox method) test.
Results
Knocking down each of several C. elegans α-arrestins marginally influenced lifespan
We measured the lifespan of wild-type and long-lived daf-2 mutant animals upon knocking down each of 24 of 29 genes encoding putative α-arrestin proteins ( Figure 1A ). We used daf-16 RNAi that largely suppressed the longevity of daf-2(-) mutants as a positive control ( Figure 1B, Figure S1A , Table S2) 17,18 . We found that knockdown of each of individual α-arrestin genes tended to slightly reduce lifespan in wild-type or in daf-2(-) mutants ( Figure 1B , Figure S1B -U, Table S2 ). Out of the 24 RNAi clones, RNAi targeting arrd (arrestin domain protein)-13, arrd-16, arrd-23, arrd-24 or arrd-25 in wild-type, and RNAi against arrd-1, arrd-2, arrd-5, arrd-24 or arrd-28 in daf-2(-) mutant animals decreased lifespan by more than 5% ( Figure 1B-E, Figures S1B, D , K, Q, R, T, Table S2 ). Specifically, arrd-16 RNAi decreased lifespan in wild-type by 9%, and arrd-1 RNAi decreased lifespan in daf-2(-) mutants by 7% ( Figure 1B and C) . In addition, RNAi targeting arrd-24 decreased the lifespan of wild-type and daf-2 mutant animals by 11% and 6%, respectively ( Figure 1E ). In contrast, arrd-3 RNAi increased the lifespan of wild-type animals by 10% ( Figure 1F ). Overall, genetic inhibition of individual α-arrestin genes using RNAi appears to have minor effects on C. elegans lifespan. Mean lifespan, ages at different percent mortality, linear interpolation of mortality curve at specific mortality rate were calculated from pooled lifespan data of two independent lifespan experiments. Data were obtained using OASIS2 (https://sbi. postech.ac.kr/oasis2/). Statistical test results (Chi square, p value, Bonferroni p value) were calculated between 'condition 1' and 'condition 2'. Test results were obtained using OASIS2 (https://sbi.postech.ac.kr/oasis2/).
Discussion
The lifespan-regulatory functions of α-arrestins remain largely unexplored at the organism level. Here we showed that RNAi knockdown of individual C. elegans α-arrestins had small or no effects on lifespan in wild-type or daf-2 mutants. Our study has limitations that need to be considered for interpretation. First, RNAi targeting some α-arrestins might be insufficient for causing strong lifespan phenotypes. This may be because many of C. elegans α-arrestins are predicted to be expressed in neurons 7, 9, [24] [25] [26] , which are refractory to RNAi [27] [28] [29] . Lifespan assays using RNAi-hypersensitive mutants, including rrf-3(-) and eri-1(-) animals [29] [30] [31] , treated with α-arrestin RNAi, or using α-arrestin null mutants will help address this issue. In addition, as we did not test whether RNAi targeting each of α-arrestin genes was effective by using quantitative RT-PCR, our negative data should be interpreted with caution. Second, C. elegans α-arrestins may have functional redundancy, considering the large number of the α-arrestin family members in C. elegans and their sequence similarity 1, 7 , which may obscure examining the functional importance of each α-arrestin. In addition, some α-arrestins may mostly function by modulating the action of their interacting proteins 6 . In this case, genetic inhibition of α-arrestins may rather subtly affect the functions of their interacting partners that directly regulate physiology, such as aging and longevity, causing weak or no phenotypes. Thus, it will be interesting to test the effects of simultaneous inhibition of α-arrestins possibly through targeting the arrestin domain, and to identify and to functionally characterize proteins that bind C. elegans α-arrestins. Third, it is possible that three α-arrestins, arrd-12, arrd-22 and arrd-27, which were not tested in our screen, may play crucial roles in lifespan regulation. Thus, it will be important to examine if genetic inhibition of each of these three α-arrestin genes affects lifespan in future studies. Figure S1 . RNAi knockdown of each Caenorhabditis elegans α-arrestin had minor effects on the lifespan of wild-type or daf-2(-) mutants. (A-U). Lifespan curves of wild-type (WT) and daf-2(e1370) (daf-2(-)) mutants treated with RNAi targeting daf-16 (A), which was used as a positive control, arrd-2
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, arrd-28 (T) and ttm-2 (U). See Table S2 for statistical analysis and for additional repeats of lifespan data using daf-16 RNAi. Click here to access the data. Table S1 . Possible RNAi target prediction. RNAi clones used in the screen were examined for their possible off-targets by Clone Mapper (http://bioinformatics.lif.univ-mrs.fr/RNAiMap) 22 . For RNAi clone names, 'mv' indicates an RNAi clone from Vidal library and 'sjj' indicates an RNAi clone from Ahringer library. RNAi clones generated by us for this study are labeled as 'Lee lab'. Scores for potential target transcripts were calculated as described previously 22 and were rounded off to the second digit after the decimal point.
Click here to access the data. Table S2 . Lifespan data of Caenorhabditis elegans α-arrestin RNAi clones. Lifespan data within the solid lines indicate the pooled experimental datasets that are performed at the same time by two independent researchers. P values were calculated within the sets using log-rank (Mantel-Cox) method
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. Percent (%) changes and p values for the lifespan data of specific α-arrestin RNAi-treated wild-type (WT) and daf-2(e1370) worms were calculated against those of control RNAi-treated WT and daf-2(e1370) worms within the sets, respectively. Percent (%) changes and p values for the lifespan data of control RNAi-treated daf-2(e1370) mutants were calculated against those of control RNAi-treated WT worms. SEM represents standard error of the mean, and 75th percentile indicates the age (days) at 75% mortality. Click here to access the data.
In mammals, several α-arrestins are implicated in metabolic regulation 5 . TXNIP (thioredoxin-interacting protein), an inhibitor of thioredoxin in mammals [32] [33] [34] , is a crucial negative regulator of glucose uptake 35, 36 . ARRDC4 inhibits glucose uptake in cultured mammalian cells as well 36 , and ARRDC3 deficiency protects against obesity in male mice through increasing energy expenditure 37 . Because metabolism is closely associated with aging 38 , it will be interesting to test whether α-arrestins in complex metazoans play roles in aging via regulating metabolism. 1.
2.
3.
(2) I think it is fair to say that none of the 24 genes extended lifespan when knocked down. The statistically significant 10% increase of wild-type lifespan by arrd-3 RNAi is negligible, given the variation of the lifespan assay. The relatively small p-value (0.0045) is blessed by the large sample size (n = 240). I wonder what the p-values would be if the two independent lifespan experiments had not been pooled. (3) I would like the authors to report how many worms were censored. (4) I wonder whether the authors had observed any noticeable phenotypes from their RNAi experiments, in particular, egg-laying defects. Strong egg-laying defects are easy to detect. G-protein signaling and beta-arrestin regulate the egg-laying behavior. We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.
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